Revenue: The sum of all revenue fields included for a company's operating activities.
Capricor Therapeutics, Inc. (CAPR) had Revenue of $22.27M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$22.27M |
$-40.47M |
|
-- |
|
$22.27M |
|
$64.84M |
|
$-42.56M |
|
$2.10M |
|
$-40.47M |
|
$-40.35M |
|
$-40.47M |
|
$-40.47M |
|
$-40.47M |
|
$-40.35M |
|
$-42.56M |
|
$-41.14M |
|
35.22M |
|
35.22M |
|
$-1.15 |
|
$-1.15 |
|
| Balance Sheet Financials | |
$163.39M |
|
$5.56M |
|
$7.10M |
|
$170.48M |
|
$21.03M |
|
-- |
|
$3.99M |
|
$25.02M |
|
$145.46M |
|
$145.46M |
|
$145.46M |
|
45.58M |
|
| Cash Flow Statement Financials | |
$-40.00M |
|
$-116.18M |
|
$152.77M |
|
$14.69M |
|
$11.29M |
|
$-3.41M |
|
$9.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.77 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-191.13% |
|
-191.13% |
|
-184.73% |
|
-181.71% |
|
-181.71% |
|
$-41.53M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
-- |
|
2.15 |
|
169.93 |
|
-27.82% |
|
-27.82% |
|
-23.74% |
|
-27.82% |
|
$3.19 |
|
$-1.18 |
|
$-1.14 |
|